#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Encephalitis autoimmune Extra-osseous Ewing's sarcoma Malignant melanoma Lymphatic malformation Lupus nephritis Severe myoclonic epilepsy of infancy Hidradenitis Arterial tortuosity syndrome Rhabdomyosarcoma recurrent Congenital myopathy Type IIa hyperlipidaemia Follicular lymphoma Haematological malignancy Rheumatoid arthritis Non-small cell lung cancer recurrent More trials…

    Learn about Rare Diseases

    Turner’s syndrome – Diagnostics Wiskott-Aldrich syndrome – Life with Disease Toxic epidermal necrolysis – Life with Disease Malignant fibrous histiocytoma – Life with Disease Vascular malformation – Life with Disease Haemophagocytic lymphohistiocytosis – Basic Information Synovial sarcoma Osteosarcoma metastatic – Treatment Prolymphocytic leukaemia – Diagnostics Systemic sclerosis pulmonary – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mercaptamine Tasipimidine Vinorelbine Tartrate Rasagiline 177Lu-Dpi-4452 Ict01 Eltrombopag Aminocaproic Acid Posenacaftor BMS-986365 Fosphenytoin Sodium Demeclocycline Hydrochloride Thiamazole Rosuvastatin Sirolimus Blinatumomab Efpegerglucagon Sotatercept Anhydrous Cidofovir Tirzepatide More therapies…

    Learn about Your Condition

    Paraganglion neoplasm Inborn error of metabolism Indolent systemic mastocytosis Neonatal anoxia Diabetic retinal oedema Generalised anxiety disorder Appendicitis SAPHO syndrome Retinitis pigmentosa Magnetic resonance imaging Alcoholism Breast cancer in situ Nasal sinus cancer Gout Respiratory failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on Gadobutrol for Patients with Idiopathic Normal Pressure Hydrocephalus to Understand Cerebrospinal Fluid Movement Using MRI

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Flutemetamol (18F)
    • Gadobutrol
    Sweden

  • Study on Water Absorption in the Brain for Adults with Hydrocephalus Using O15-Water

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hydrocephalus
    Investigated Drugs:
    • O15-Water
    Norway

  • Study on the Safety and Effects of YTB323, Tocilizumab, and Cyclophosphamide in Patients with Relapsing Multiple Sclerosis Who Have Active Disease Despite Treatment

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Rapcabtagene Autoleucel
    • Cyclophosphamide
    • Fludarabine Phosphate
    France Germany Italy Spain

  • Study on Daridorexant’s Effect on Cognitive Performance in Patients with Chronic Insomnia Disorder

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Insomnia
    Investigated Drugs:
    • Daridorexant
    Italy

  • Study on the Safety and Effectiveness of C1 Esterase Inhibitor and Sodium Chloride for Patients with Aneurysmal Subarachnoid Hemorrhage

    Recruiting

    2 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • C1 Esterase Inhibitor (Human)
    • Sodium Chloride
    The Netherlands

  • Study on the Effects of Lysergide for Patients with Chronic Cluster Headache

    Recruiting

    2 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • LYSERGIDE
    The Netherlands
Previous Page
1 … 21 22 23 24 25 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!